Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0162 Transporter Info | ||||
Gene Name | SLC24A1 | ||||
Transporter Name | Sodium/potassium/calcium exchanger 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg22374485) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:4.81E+00 | Statistic Test | p-value:6.75E-36; Z-score:1.84E+01 | ||
Methylation in Case |
2.95E-01 (Median) | Methylation in Control | 6.13E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC24A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg19876838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.92E-07; Z-score:-1.23E+00 | ||
Methylation in Case |
8.02E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC24A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg04230910) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:9.43E-05; Z-score:-5.98E-01 | ||
Methylation in Case |
7.57E-02 (Median) | Methylation in Control | 1.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC24A1 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg08831522) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:9.05E-03; Z-score:7.68E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 7.56E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg00431427) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:9.56E-04; Z-score:-8.20E+00 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC24A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg18193482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:2.28E-05; Z-score:5.54E+00 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00431427) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:6.91E-08; Z-score:-1.48E+00 | ||
Methylation in Case |
7.96E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC24A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg07116160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.51E-02; Z-score:-7.02E-01 | ||
Methylation in Case |
8.64E-01 (Median) | Methylation in Control | 8.89E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC24A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg01704999) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:7.43E-05; Z-score:6.76E-01 | ||
Methylation in Case |
1.09E-01 (Median) | Methylation in Control | 9.77E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC24A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg18193482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.30E-03; Z-score:-9.57E-01 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 9.09E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg00431427) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:7.28E-09; Z-score:-3.30E+00 | ||
Methylation in Case |
8.40E-01 (Median) | Methylation in Control | 9.00E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC24A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg18193482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:6.02E-04; Z-score:9.74E-01 | ||
Methylation in Case |
9.21E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC24A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg01704999) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.11E-03; Z-score:5.38E-01 | ||
Methylation in Case |
1.93E-01 (Median) | Methylation in Control | 1.81E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Epigenetic regulation in BRAF-mutated CRC | [ 7 ] | |||
Location |
Genome-wide | ||||
Epigenetic Type |
Methylation | Experiment Method | Metabolomics & epigenomic profiling | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B90] | ||||
Experimental Material |
39 MSS BRAF-mutated CRC tumors | ||||
Additional Notes |
SLC24A1 is implicated in the hypermethylation phenotype of microsatellite-stable BRAF-mutated CRC. Low vitamin C levels (regulated by SLC23A1) may reduce TET demethylase activity, contributing to global hypermethylation. | ||||
Hepatocellular carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg00431427) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:5.51E-07; Z-score:-1.48E+00 | ||
Methylation in Case |
7.86E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC24A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg14601251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.95E-05; Z-score:-9.37E-01 | ||
Methylation in Case |
8.45E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC24A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg20330315) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.20E-03; Z-score:-5.00E-01 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC24A1 in papillary thyroid cancer | [ 6 ] | |||
Location |
TSS1500 (cg14601251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.19E-05; Z-score:2.18E+00 | ||
Methylation in Case |
8.98E-01 (Median) | Methylation in Control | 8.14E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of SLC24A1 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.23E-10; Fold-change:-0.280112254; Z-score:-1.861762716 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Esthesioneuroblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC24A1 in esthesioneuroblastoma than that in healthy individual | ||||
Studied Phenotype |
Esthesioneuroblastoma [ICD-11:2D50.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.71E-07; Fold-change:-0.39108765; Z-score:-2.515422902 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Medulloblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC24A1 in medulloblastoma than that in healthy individual | ||||
Studied Phenotype |
Medulloblastoma [ICD-11:2A00.10] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.08E-41; Fold-change:-0.342164428; Z-score:-1.90683029 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC24A1 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:6.93E-20; Fold-change:-0.44643774; Z-score:-3.110669103 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.